【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Driver Analysis
4.2.1. Increasing number of pipeline drugs
4.2.2. Growing prevalence of genitourinary disorders
4.3. Market Restraint Analysis
4.3.1. Increasing advent of counterfeit drugs
4.3.2. Growing generics drug competition
4.3.3. High number of patent expirations in the coming years
4.4. Penetration & Growth Prospect Mapping
4.5. Genitourinary Drugs – SWOT Analysis, By Factor (political & legal, economic and technological)
4.6. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Indication Estimates & Trend Analysis
5.1. Genitourinary Drugs Market: Indication Movement Analysis
5.2. Prostate Cancer
5.2.1. Prostate cancer market estimates and forecasts, 2013 – 2024 (USD Million)
5.3. Ovarian Cancer
5.3.1. Ovarian cancer market estimates and forecasts, 2013 – 2024 (USD Million)
5.4. Bladder Cancer
5.4.1. Bladder cancer market estimates and forecasts, 2013 – 2024 (USD Million)
5.5. Cervical Cancer
5.5.1. Cervical cancer market estimates and forecasts, 2013 – 2024 (USD Million)
5.6. Renal Cancer
5.6.1. Renal cancer market estimates and forecasts, 2013 – 2024 (USD Million)
5.7. Erectile Dysfunction
5.7.1. Erectile dysfunction market estimates and forecasts, 2013 – 2024 (USD Million)
5.8. Urinary Tract Infections
5.8.1. Urinary tract infections market estimates and forecasts, 2013 – 2024 (USD Million)
5.9. Urinary Incontinence & Overactive Bladder
5.9.1. Urinary incontinence & overactive bladder market estimates and forecasts, 2013 – 2024 (USD Million)
5.10. Sexually Transmitted Diseases
5.10.1. Sexually transmitted diseases market estimates and forecasts, 2013 – 2024 (USD Million)
5.11. Interstitial Cystitis
5.11.1. Interstitial cystitis market estimates and forecasts, 2013 – 2024 (USD Million)
5.12. Hematuria
5.12.1. Hematuria market estimates and forecasts, 2013 – 2024 (USD Million)
5.13. Benign Prostatic Hyperplasia
5.13.1. Benign Prostatic Hyperplasia market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: Product Estimates & Trend Analysis
6.1. Genitourinary Drugs Market: Product Movement Analysis
6.2. Urologicals
6.2.1. Urologicals market estimates and forecasts, 2013 – 2024 (USD Million)
6.3. Hormonal Therapy Drugs
6.3.1. Hormonal therapy drugs market estimates and forecasts, 2013 – 2024 (USD Million)
6.4. Gynecological
6.4.1. Gynecological market estimates and forecasts, 2013 – 2024 (USD Million)
6.5. Anti-infectives
6.5.1. Anti-infectives market estimates and forecasts, 2013 – 2024 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: Regional Estimates & Trend Analysis, By Indication & Product
7.1. Genitourinary Drugs Market Share By Region, 2015 & 2024
7.2. North America
7.2.1. North America market estimates and forecasts, by indication, 2013 – 2024 (USD Million)
7.2.1.1. U.S. market estimates and forecasts
7.2.1.2. Canada market estimates and forecasts
7.2.2. North America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
7.2.2.1. U.S. market estimates and forecasts
7.2.2.2. Canada market estimates and forecasts
7.3. Europe
7.3.1. Europe market estimates and forecasts, by indication, 2013 – 2024 (USD Million)
7.3.1.1. UK market estimates and forecasts
7.3.1.2. Germany market estimates and forecasts
7.3.2. Europe market estimates and forecasts, by product, 2013 – 2024 (USD Million)
7.3.2.1. UK market estimates and forecasts
7.3.2.2. Germany market estimates and forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific market estimates and forecasts, by indication, 2013 – 2024 (USD Million)
7.4.1.1. Japan market estimates and forecasts
7.4.1.2. China market estimates and forecasts
7.4.1.3. India market estimates and forecasts
7.4.2. Asia Pacific market estimates and forecasts, by product, 2013 – 2024 (USD Million)
7.4.2.1. Japan market estimates and forecasts
7.4.2.2. China market estimates and forecasts
7.4.2.3. India market estimates and forecasts
7.5. Latin America
7.5.1. Latin America market estimates and forecasts, by indication, 2013 – 2024 (USD Million)
7.5.1.1. Brazil market estimates and forecasts
7.5.1.2. Mexico market estimates and forecasts
7.5.2. Latin America market estimates and forecasts, by product, 2013 – 2024 (USD Million)
7.5.2.1. Brazil market estimates and forecasts
7.5.2.2. Mexico market estimates and forecasts
7.6. MEA
7.6.1. MEA market estimates and forecasts, by indication, 2013 – 2024 (USD Million)
7.6.1.1. South Africa market estimates and forecasts
7.6.2. MEA market estimates and forecasts, by product, 2013 – 2024 (USD Million)
7.6.2.1. South Africa market estimates and forecasts
Chapter 8. Competitive Landscape
8.1. Market Participation Categorization
8.2. Company Profiles
8.2.1. Abbott
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Bristol-Myers Squibb Co.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Novartis AG
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Genentech, Inc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Ionis Pharmaceuticals, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Eli Lilly and Company
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Merck & Co., Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Pfizer, Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. AstraZeneca
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. GlaxoSmithKline
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Teva Pharmaceutical Industries Ltd.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Bayer AG
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2.14. Allergan
8.2.14.1. Company overview
8.2.14.2. Financial performance
8.2.14.3. Product benchmarking
8.2.14.4. Strategic initiatives
8.2.15. Antares Pharma
8.2.15.1. Company overview
8.2.15.2. Financial performance
8.2.15.3. Product benchmarking
8.2.15.4. Strategic initiatives
【レポート販売概要】
■ タイトル：泌尿生殖器薬の世界市場分析：指示薬別（前立腺、卵巣、膀胱、子宮頸がん、勃起不全、尿路感染症、尿失禁およびSTD）、製品別（泌尿器科学、ホルモン療法薬、婦人科、抗感染薬）、セグメント予測、2013 – 2024■ 英文：Genitourinary Drugs Market By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, Erectile Dysfunction, UTI, Urinary Incontinence & STD) By Product (Urologicals, Hormonal Therapy Drugs, Gynecological, Anti-infectives) And Segment Forecasts, 2013 - 2024
■ 発行日：2016年11月15日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707355
■ 調査対象地域：グローバル
- 世界の高度HVAC（暖房・換気・空調）制御市場（2014-2018）About Advanced HVAC Control Systems HVAC control systems are used to efficiently handle HVAC equipment. They allow building owners to resourcefully manage their building energy consumption. Moreover, these systems are designed to eliminate the difficulty of managing HVAC systems and to enhance their performance. There are various types of HVAC control systems including sensors, field devices, floo …
- ゲーム機周辺機器の世界市場：ゲームコントローラ、ヘッドセット、キーボード、マウス、マウスパッドAbout gaming peripheral Initially, games were restricted to board games and associated video games. However, the introduction and popularity of PCs and electronic devices and a rise in the use of the internet have led to the development and commercialization of gaming. The gaming peripherals market is witnessing an exponential growth worldwide because of the rapid adoption of gaming. In terms of t …
- 高密度ポリエチレン(HDPE)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world polyethylene high density market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together giv …
- スマートロボットの世界市場：個人向けサービスロボット、スマートモバイルロボット、協力ロボットAbout the Smart Robots Market Robotic vacuum cleaners emerged in the market in the late 1990s and early 2000s. However, the adoption of robotic vacuum cleaners remained low during the both the periods due to product inefficiencies like limited suction power and random movement pattern to clean floors. However, technological innovations, availability of new advanced products such as infrared sensor …
- 呼吸保護装置の世界市場予測（～2022年）：空気浄化式人工呼吸器、送気式人工呼吸器The respiratory protection equipment market is projected to grow at a CAGR of 6.8% during the forecast periodThe respiratory protection equipment market is estimated at USD 5.25 billion in 2017 and is projected to reach USD 7.28 billion by 2022, at a CAGR of 6.8% from 2017 to 2022. The growth of the respiratory protection equipment market is primarily due to the rising awareness about workplace sa …
- 主要先進国における膵臓癌(膵癌)治療動向（～2019）Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets …
- 世界のヘリコバクター・ピロリ検査市場The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 世界の液体分析機器市場動向（2012-2016）TechNavio’s analysts forecast the Global Liquid Analytical Instrument market to grow at a CAGR of 6.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for better analysis. The Global Liquid Analytical Instrument market has also been witnessing an evolution from laboratory technology to a process environment. However, the premium pric …
- テレコムネットワークインフラ市場（Telecom Network Infrastructure Market 2013-2018）The telecommunications infrastructure vendor market consists of a variety of companies that provide switching, transmission, signaling, database, content, applications, OSS/BSS systems, and other equipment, software, and services. In recently years, major infrastructure vendors have face many challenges including tightening carrier budgets, technology evolution, and business model evolution. The t …
- メチルエチルケトン（MEK/ブタノン）の世界市場2015-2019About MEK MEK also known as butanone is a colorless organic solvent with a pleasant pungent odor. It is used as a solvent for multiple applications due to its outstanding chemical properties such as high viscosity, high evaporation rate, low boiling point, and high solvency. MEK is used in paints and coatings, adhesives and thinners, printing inks, pharmaceutical products, and others. Technavio's …
- JordanのPotassium Hydroxide (Caustic Potash)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Jordan and its perspectives on the global market for potassium hydroxide (caustic potash). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on potassium hydroxide (caustic potash) export/import operations in Jordan …
- Anorexia Nervosa：グローバル臨床試験レビューH1, 2013Anorexia Nervosa Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2013" provides data on the Anorexia Nervosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anorexia Nervosa. It includes an overview of the trial numbers and their recruitment statu …
- 動物飼料用プロバイオティクスの世界市場：乳酸菌、サーモフィラス菌、ビフィズス菌The market for probiotics in animal feed is projected to grow at a CAGR of 7.7% from 2016 to reach a projected value of USD 4.71 Billion by 2021. The market is further driven by factors such as increase in demand for quality animal products and increased focus on animal health to prevent disease outbreaks. Based on bacteria, the market for probiotics in animal feed is estimated to be led by the la …
- 腎機能検査の世界市場分析：製品別（希釈・濃縮、クリアランス、尿、画像検査）、エンドユーザー別（病院、診断研究所、学術研究所）、セグメント予測、2014-2025The global kidney function tests market is expected to reach USD 1.9 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of Chronic Kidney Diseases (CKD) and renal failure is presumed to be responsible for the high urgency to use kidney function tests, which is anticipated tobroaden the scope for growth throughout the forecast period. In addition, expandin …
- 能動型騒音・振動制御（ANVC）システムの世界市場予測（～2022年）“The increasing use of active noise and vibration control system to enhance passenger comfort is one of the key factors expected to drive the growth of the market”The active noise and vibration control system market is projected to grow from USD 2.16 billion in 2016 to USD 2.93 billion by 2022, at a CAGR of 5.15% during the forecast period. Growth of this market is mainly driven by the increasing …
